Headquartered in Scottsdale, Arizona since 1991, Rowpar Pharmaceuticals, Inc. is an organization dedicated to providing innovative oral health solutions. ClōSYS® Oral Health products help people live healthier lives.
Its motto is “A Cleaner Mouth, A Healthier You®", connecting oral and systemic health. Cloralstan® is Rowpar’s patented core technology. ClōSYS products are proven effective in killing various oral pathogens associated with plaque, gum diseases and other oral diseases, and for reducing oral malodor, dry mouth, sensitive mouth, and oral mucositis resulting from chemotherapy as well. We recently began representing the company to expand awareness of the benefits of ClōSYS mouthwash and other products that help ease symptoms of mouth sores caused by chemotherapy, radiation and drugs. ClōSYS mouthwash users don't have problems eating, taking medicine or drinking water. Mouth sores can become so severe they require hospitalization, which can delay treatment, sabotaging the patient's chance for survival.
Since its establishment in 1991, Rowpar has maintained its leadership position by way of inventing new products and applications and acquiring patents worldwide. In the last 18 months, Rowpar was recognized for product excellence and has expanded both its global distribution network and its product line. On October 11, 2017 Rowpar will be recognized by the Arizona Bioindustry Association with a Fast Lane Award for its ClōSYS® Oral Health products.
Rowpar products are used by dental and medical professionals and are available on a retail basis in North America, Europe, Australia and Asia. Its ClōSYS® brand is recommended by dentists and hygienists, and is among the top selling oral care products in CVS, Walgreens, Walmart and Amazon nationally, with additional new retailers, new stores and new shelves being added in the past 18 months.